Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Homologous/Autologous Blood Doping- a Transfusion Study

NCT03548766 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT03548766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03548766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Homologous/Autologous Blood Doping- a Transfusion Study
Lead sponsor
Hamad Medical Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
September 20, 2018
Completion date
December 31, 2021
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood disease, blood doping, blood transfusion, autologous, blood transfusion, homologous